Vermont stands to receive more than $300,000 through two settlements with pharmaceutical companies, Attorney General William Sorrell announced Monday.The state will receive $196,000 of a $422.5 million settlement Novartis Pharmaceuticals Corp. entered with all 50 states, the District of Columbia and the federal government, Sorell said.
The state also will receive $95,000 of a $75 million settlement Ortho-McNeil-Janssen Pharmaceuticals Inc. entered with the same parties, he said.The agreement with Novartis resolves allegations the company paid kickbacks to psychiatrists and other health-care professionals, in the form of payments for speaker programs, advisory boards, entertainment and gifts to induce them to promote and prescribe six drugs, Sorrell said.
The agreement with Ortho-McNeil-Janssen resolves allegations the company promoted topiramate, an antiepileptic and migraine-prevention drug marketed under the trade name Topamax, for uses not approved by the Food and Drug Administration.The off-label marketing included promoting the drug for psychiatric conditions, including bipolar disorder and drug and alcohol dependency.
Ortho-McNeil-Janssen also pleded guilty to a criminal misdemeanor violation of the Food, Drug and Cosmetic Act.
The state also will receive $95,000 of a $75 million settlement Ortho-McNeil-Janssen Pharmaceuticals Inc. entered with the same parties, he said.The agreement with Novartis resolves allegations the company paid kickbacks to psychiatrists and other health-care professionals, in the form of payments for speaker programs, advisory boards, entertainment and gifts to induce them to promote and prescribe six drugs, Sorrell said.
The agreement with Ortho-McNeil-Janssen resolves allegations the company promoted topiramate, an antiepileptic and migraine-prevention drug marketed under the trade name Topamax, for uses not approved by the Food and Drug Administration.The off-label marketing included promoting the drug for psychiatric conditions, including bipolar disorder and drug and alcohol dependency.
Ortho-McNeil-Janssen also pleded guilty to a criminal misdemeanor violation of the Food, Drug and Cosmetic Act.
No comments:
Post a Comment